A crucial barrier to breach {#sec0005}
===========================

A first step during infection is the attachment of microorganisms to various host proteins, which could include basement membrane (BM) proteins. Generally, adhesion of bacteria and fungi occurs through binding of adhesive molecules, called adhesins, to host proteins. Most adhesins are extensively described and some of the motifs participating in these processes have been identified. In comparison, knowledge about adhesion of viruses to BM components is scarce. On adhesion, microorganisms have evolved cunning techniques to overcome the BM barrier, which otherwise hampers their invasive process. Breakdown of the BM, via activation of microbial and/or host proteases, to cross the BM has been shown for many bacteria, fungi and, recently, some viruses. Pathogens might also gain access to the connective tissue by hijacking host cells, particularly local immune cells, to cross the BM. This review provides an overview of recent insights into different pathogen--BM interactions during host invasion, discusses these findings and projects how they could contribute to the design of novel strategies to interfere with microbial invasions and pathology.

The BM: a specialized extracellular matrix possessing unique properties {#sec0010}
=======================================================================

The BM provides a subtle interface between epithelial or endothelial cells and mesenchymal cells present in connective tissue. Besides providing tissue structure, the BM plays an important role in structural integrity, cell behavior and signaling [@bib0005]. In proximity to epithelial cells, BM components such as collagen XVII and laminin 5, 6 and 10 are linked to extracellular parts of different molecules, mainly belonging to the integrin family (e.g. α6β4, α5β1 and α9β1) and fibronectin network, present on basolateral cell surfaces. At the cellular--matrix interface, located underneath the cell-neighboring elements collagen IV, VII and XVIII, laminin 1, entactin/nidogen, BM-40/osteonectin, fibulins and proteoglycans such as bamacan, agrin, perlecan are abundant. Towards the lamina propria, collagen I, III, V and VI appear next to proteoglycans. Overall, the BM represents a firm network of the main components, collagen and laminin, bridged by various other components ([Figure 1](#fig0005){ref-type="fig"} ). Importantly, the average pore size in the collagen--laminin network is approximately 50 nm, which allows only very small particles to diffuse across this thin but firm barrier [@bib0010], [@bib0015]. This implies that microorganisms have devised ways to cross the BM.Figure 1Immune cell trafficking through the basement membrane (BM) network. **(a)** Transmission electron micrograph of the BM zone. **(b)** Schematic illustration of a BM network and its main components. Laminin polymerization is believed to initiate the BM scaffold organization. Deposition of this polymer leads to association with a type IV collagen network. The other components of the BM interact with the laminin polymer and the type IV collagen network to organize a functional BM on the basolateral aspect of cells. **(c)** Despite the small pore size of the BM, immune cells scanning for signs of infection routinely traverse it. The BM transmigration program is a conserved mechanism. First, immune cells adhere to the matrix in an integrin-mediated manner. Subsequently, proteases degrade the BM before actin polymerization extends cell protrusions through the hole. Finally, the cell body moves behind the actin-rich protrusion.

Adhesion of pathogens to BM components {#sec0015}
======================================

A crucial initial event in the pathogenesis of many microorganisms is adhesion to host tissues. Major players during these early steps in infection are microbial adhesive cell-surface molecules, termed adhesins [@bib0020]. Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) are adhesins that attach to extracellular matrix (ECM) including the BM. Many MSCRAMMs are capable of binding more than one ECM component, and a single strain often possesses several different proteins that bind the same host component. Although current data about viral ECM adhesion and adhesins are still scarce, their importance in virulence has been shown for most bacteria and many fungi. For example, in many animal models of staphylococcal infections, CNA, a collagen-binding adhesin of pathogenic *Staphylococcus aureus*, increases disease severity. It has been suggested that the ability to interact with collagen grants these bacteria a clear advantage in pathogenesis [@bib0025]. For bacteria, adhesins are roughly subdivided according to the appendage morphology: there are fimbrial or non-flagellar adhesins (chaperone-usher pili, curli, type IV pili, type III secretion needle and type IV secretion pili) and non-fimbrial adhesins (autotransporters; outer membrane, secreted and biofilm-associated adhesins). Pili are further classified according to physical properties, antigenic determinants, adhesion characteristics, and characteristics of the major protein subunits or assembly pathways [@bib0030], [@bib0035]. Although adhesins form a heterogeneous group with diverse architecture, domain content and binding mechanism, some do possess similarity in structure, ECM-binding domain organization and function [@bib0040], [@bib0045]. ECM-binding MSCRAMMs of many pathogenic Gram-positive species are cell-wall-anchored surface proteins (CWPs). Common features of CWPs are an N-terminal signal peptide followed by a so-called A region or domain, segments of repeated domains and a characteristic C-terminal sorting signal. The sorting signal contains an important cell-wall-anchoring site or LPXTG motif, which covalently binds to the cell wall [@bib0050], [@bib0055]. However, it has recently been shown that the collagen-binding adhesin Slr of Gram-positive *Streptococcus pyogenes* lacks the LPXTG motif, but uses a cell-wall-anchoring TLIA lipobox instead [@bib0060]. The structure and organization of viral and fungal adhesins to ECM are less well documented at present, although there is proof of diversity in fungal adhesins [@bib0040], [@bib0065]. Some fungal adhesins show structural and/or functional similarities to bacterial adhesins [@bib0040], [@bib0065]. Agglutinin-like sequence (Als) adhesins of *Candida albicans* are composed of a signal peptide, an N-terminal region, a nonrepeat Thr-rich (TR) region, a central region with a variable number of repeats, and a Ser/Thr/Asn-rich C-terminal domain that anchors the CWP via a glycophosphatidyl inositol (GPI) remnant [@bib0065], [@bib0070]. In many cases, ECM-binding domains recognize carbohydrate residues or oligosaccharides, but not exclusively, because many of them also bind host protein-binding sites [@bib0050], [@bib0075], [@bib0080]. Besides this direct microbial adhesin-ligand binding, microorganisms have developed other interesting indirect adhesive approaches. *Haemophilus influenzae*, *Moraxella catarrhalis* and *Shigella* spp. prevent cell detachment of infected cells from the BM through stabilization of focal adhesions. This strategy counteracts rapid exfoliation, which is an effective intrinsic defensive system of intestinal epithelium [@bib0085]. *C. albicans* promotes laminin 5 and type IV collagen protein secretion to enhance binding to the BM [@bib0090]. In the following paragraphs, adhesion of bacteria, fungi and viruses to the major BM components collagen, laminin, proteoglycans, entactin/nidogen, BM-40 and fibulin is discussed in more detail. Bacteria, fungi and viruses also show binding capacity to fibronectin, a minor component of the BM zone, that is extensively described elsewhere [@bib0095].

Collagen, the superhelix {#sec0020}
------------------------

Three collagen polypeptide chains, called α chains, are rich in proline and glycine and together constitute a long, stiff, rope-like superhelix known as the typical collagen molecule [@bib0005], [@bib0010], [@bib0015], [@bib0100]. Numerous bacteria are able to interact with collagens via their proper adhesins [@bib0100], [@bib0105], [@bib0110]. For many bacterial species, the ability to interact with collagen in the BM is a prerequisite for invasiveness. For example, PilA from *Streptococcus agalactiae*, causing meningitis in newborns, binds collagen I, which promotes interaction with integrins and subsequent penetration of the blood--brain barrier (BBB) [@bib0115].

Some fungal pathogens also interact with collagens during host invasion using distinct fungal receptors. *Aspergillus fumigatus* contains a sialic acid-specific lectin that interacts with collagen types I and IV [@bib0120]. Similarly, the Als3p glycoprotein, a major player in *C. albicans* pathogenesis, is responsible for binding collagen IV [@bib0125]. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and glycoprotein gp43 of *Paracoccidioides brasiliensis* bind type I collagen. Gp43 also binds type IV collagens and laminin, probably via a sialic acid recognition system, similar to *A. fumigatus* [@bib0120]. However, for most fungi, adhesins and adhesive mechanisms are still largely unknown [@bib0065], [@bib0070].

So far, viral binding to collagen has not been described.

The multidomain glycoprotein laminin {#sec0025}
------------------------------------

Three laminin chains (α,β,γ) form an asymmetric cross-like subunit via disulfide bonds. This non-collagenous protein contains multiple binding domains for interactions with ECM components (domains III, IV, V and VI) and with cellular receptors (G domain) [@bib0005], [@bib0010], [@bib0015]. As described for collagen, many different bacteria and fungi are able to interact with laminins via adhesive proteins [@bib0030], [@bib0130], [@bib0135], [@bib0140], [@bib0145]. Most adhesins recognize multiple molecules. However, there are adhesins that bind laminin but not collagen. Lsa24 and Lsa27 of *Leptospira interrogans* [@bib0130], Lmb of *Streptococcus agalactiae* [@bib0135] and others act as specific laminin-binding adhesins. Recently, ErpX of *Borellia burgdorferi* was found to have a unique mode of laminin binding through a hydrophobic segment at the center of the bacterial protein. This protein motif has not been identified yet in other bacterial laminin adhesins [@bib0145].

For human papillomaviruses (HPV), recent work has proposed laminin 5 as a possible basal ECM receptor. This interaction localizes virus particles to the basal surface of epithelial cells where they can reach their entry receptor, integrin α~6~β~4~, the physiological binding partner of laminin 5 [@bib0150]. However, another recent publication demonstrated that different HPV types show different binding characteristics ([Figure 2](#fig0010){ref-type="fig"} ) [@bib0155]. The nonstructural protein NSP4 of rotavirus plays a key role in the development of severe gastroenteritis by binding ECM proteins laminin β3 and fibronectin. Moreover, rotavirus induces phosphatidylinositol 3-kinase (PI3K) activation in intestinal cells, causing upregulation of integrin expression, prolonged attachment of infected cells to collagen and increased virus production [@bib0160], [@bib0165].Figure 2Different viral interactions with the BM. **(a)** Before entry into cells, viruses either attach directly to cell surface receptors (e.g. herpesviruses) or via intermediate binding to an exposed BM component in epithelial microlesions (e.g. human papillomavirus, HPV). **(b)** Viral replication and local dissemination (infected cells are in pink). Local immune cells may be infected (e.g. herpesviruses and HIV). **(c)** Viruses gain access to the stroma by breaching the BM. This may happen in a protease-mediated way (e.g. pseudorabies virus, PrV), via hijacking of immune cells to transverse the BM \[e.g. equine herpesvirus 1 (EHV-1) and HIV\] or via viral-driven metastasis out of a viral-induced tumor (e.g. HPV, green cells). **(d)** Finally, viruses may spread in the host by reaching blood or lymph vessels.

The heterogeneous molecule: proteoglycan {#sec0030}
----------------------------------------

To be typed as a proteoglycan, at least one of the sugar side chains of a molecule has to be a glycosaminoglycan (GAG). All GAGs are covalently bound via a tetrasaccharide link to a serine amino acid in the core protein, the central polypeptide chain of proteoglycans [@bib0005], [@bib0010], [@bib0015]. The ability to interact with proteoglycans, often heparan sulfate proteoglycans, is widespread in viruses and bacteria [@bib0170], [@bib0175]. A clear distinction has to be made in this context between cell-surface proteoglycans, ECM-associated proteoglycans in general and specific proteoglycans residing inside the BM. Despite the numerous reports on pathogens interacting with ECM-associated proteoglycans in general [@bib0170], [@bib0175], no specific pathogen BM agrin or pathogen BM perlecan interactions have been described so far.

Currently, only one specific BM proteoglycan--pathogen interaction is known. The proteoglycan bamacan is a cellular ligand of vaccinia virus neurovirulence factor N1L. This interaction promotes viral growth and might contribute to virulence of the virus [@bib0180].

Entactin/nidogen, BM-40/osteonectin and fibulins: versatile ECM proteins {#sec0035}
------------------------------------------------------------------------

Members of the nidogen family are composed of a series of sulfated monomeric glycoproteins. Three globules, G1, G2 and G3, and one rod-like part, possessing different domains, make up the typical triglobular shape of nidogen [@bib0005], [@bib0010], [@bib0015]. BM-40 is a glycoprotein of the ECM that binds calcium, collagen and hydroxyapatite and regulates the cell--matrix interaction [@bib0005], [@bib0010], [@bib0015]. All fibulins contain epidermal growth factor-like repeats and a unique fibulin-type module at the C terminus that define this family [@bib0185]. To date, only one bacterium that uses nidogen as a potential ligand for ECM binding has been reported. SgrA of *Enterococcus faecium* has been identified as a bacterial receptor for nidogen and fibronectin [@bib0190]. The opportunistic bacterium *Finegoldia magna* depends on BM-40 interaction for colonization and survival [@bib0195]. Serum opacity factor is a streptococcal receptor for fibulin-1 [@bib0185].

No other bacteria, fungi or viruses are known to bind nidogen/entactin, BM-40 or fibulins during host invasion.

Pathogen-driven breakdown of the BM {#sec0040}
===================================

Disruption of the BM in disease states often involves proteolytic enzymes [@bib0200] and an overview of the general characteristics of the different protease types is given elsewhere [@bib0205]. Many pathogens possess the ability to produce or modulate ECM-degrading enzymes. Regulation of ECM-degrading enzymes aids pathogens in invading deeper tissues, thereby enhancing dissemination throughout the host. Besides this direct effect of pathogens on BM-degrading enzymes, pathogens might also indirectly affect such enzymes. Indeed, during inflammation of infected tissues, local immune cells produce an array of these proteolytic enzymes. This indirect activation of proteases is beyond the scope of this review.

Several bacteria encode or modulate BM-degrading proteases, either directly or by engaging host-derived systems.

Various bacterial pathogens including *Bacteroides fragilis* and *Clostridium perfringens* [@bib0210] encode or modulate matrix metalloproteinases (MMPs). Other bacteria degrade the BM barrier by encoding or modulating serine proteases. Indeed, many bacterial pathogens, such as Enterobacteriaceae, Fusobacteriaceae, Helicobacteriaceae, Legionellaceae, Mycobacteriaceae, Neisseriaceae, Pasteurellaceae, Peptostreptococcaceae, Porphyromonadaceae, Pseudomonadaceae, Spirochaetaceae, Staphylococcaceae and Streptococcaceae, modulate the plasminogen (Plg)--plasmin system [@bib0215] and the structural and functional aspects of this system are described elsewhere [@bib0220]. In brief, through the activity of the two main physiological plasminogen activators, urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA), plasminogen is converted to plasmin, which degrades laminin and fibronectin and activates precursors of MMPs. Several bacterial pathogens express plasminogen receptors, thereby recruiting plasminogen to the bacterial surface, which leads to enhanced plasminogen activation. In addition, some bacteria bind and/or induce uPA or tPA [@bib0215], [@bib0225] and/or express bacterial plasminogen activators. Moreover, some bacteria inactivate plasmin inhibitors [@bib0230].

Some bacterial species modulate multiple proteases to cross the BM. In addition to modulating the Plg system, *Streptococcus pyogenes* also expresses a cysteine protease [@bib0235]. *Fusobacterium nucleatum* can invade the BM in a strain-dependent manner by binding plasminogen [@bib0240] and pro-MMP9 and stimulating MMP9 and MMP13 secretion [@bib0245]. *Helicobacter pylori* induces expression of the cysteine protease cathepsin X in gastric epithelial cells and macrophages. In epithelial cells, *H. pylori* induces morphological and motility changes, partly via MMP9 [@bib0250] and probably also via other proteases. The mechanisms by which *H. pylori* induces expression of proteases in epithelial cells and macrophages is unknown. It has been suggested that proteolytic activities play a role in gastric tumorigenesis [@bib0250]. *H. pylori* also increases expression of the uPA system in gastric epithelial cells [@bib0255]. *Mycobacterium tuberculosis* [@bib0090], [@bib0260] and *Neisseria meningitidis* [@bib0225], [@bib0265] modulate both MMPs (MMP8 and MMP9, respectively) and the plasminogen--plasmin system. Both morphotypes of *Peptostreptococcus micros* possess plasminogen receptors. For *P. micros*, both bacterial (streptokinase) and human plasminogen activators (uPA) can activate plasminogen to plasmin. Rough morphotypes also possess chymotrypsin-like and gelatinase serine proteases [@bib0270]. *Porphyromonas gingivalis* upregulates MMPs, modulates the plasminogen--plasmin system and expresses cysteine protease gingipains. Gingipains contribute to BM penetration, either directly or by modulating MMP2 and MMP9 [@bib0275]. *Pseudomonas aeruginosa* expresses an MMP and modulates the plasminogen--plasmin system [@bib0280]. *Treponema pallidum* expresses an MMP-like and serine protease [@bib0285], induces MMPs and modulates the plasminogen--plasmin system [@bib0215]. *Vibrio* spp. express both MMPs and serine proteases [@bib0290].

Protease activity has also been implicated in tissue penetration by pathogenic fungi. Different fungi have been associated with multiple BM-degrading proteases. However, knowledge on substrate specificities and their contribution to virulence and pathogenesis is rather poor. During *Aspergillus* spp. infection, a serine protease, MMP and aspartic protease have been identified [@bib0295]. *Candida* spp. activate host MMP9, decrease tissue inhibitor of metalloproteinase 2 (TIMP2) secretion [@bib0090], and secrete aspartic proteases and unidentified MMP and serine protease activity [@bib0300]. *Cryptococcus neoformans* expresses a serine protease [@bib0305]. A total of 53 cDNAs encoding proteases were shown in *Paracoccidioides brasiliensis* including one unidentified gelatinase (collagenolytic protease) and an extracellular serine-thiol protease [@bib0310]. *P. brasiliensis* also induces MMP9 [@bib0315]. Nectriaceae, Saccharomycetaceae and Trichocomaceae also induce host MMPs [@bib0320].

It has also been reported that viruses modulate host-derived proteolytic activity to alter barrier properties of BMs, thereby enhancing viral dissemination ([Figure 2](#fig0010){ref-type="fig"}). Most viral-induced alterations of BMs involve MMPs. The latent membrane protein-1 (LMP1) of Epstein--Barr virus (EBV) induces MMP9 and uPA [@bib0325]. Hepatitis B virus x protein (HBx) drives MMP14 expression [@bib0330]. It has been reported that HPV induces MMP2, MMP9 and MMP14 [@bib0335]. The glycoprotein K1 of Kaposi\'s sarcoma-associated herpesvirus (KSHV) modulates the production of MMP1, MMP2 and MMP9 [@bib0340]. Apart from the involvement of viral-induced proteolytic activities in EBV-, hepatitis B virus-, HPV- and KSHV-induced metastasis, it is unclear at present whether this induction plays a role in viral pathogenesis. A similar mechanism is observed in human T-cell leukemia/lymphoma virus type I (HTLV-1)-associated adult T-cell leukemia/lymphoma, in which MMP9 expression is increased in HTLV-1-infected malignant cells [@bib0345], [@bib0350]. HTLV-I encephalitis is associated with MMP2 and MMP9 [@bib0350]. Other viral infections have also been implicated in neurological conditions because of their involvement in BBB impairment by damaging the vascular BM. Human cytomegalovirus (HCMV) infection of human microvascular endothelial cells (HMEC) induces collagenase type IV secretion, which may lead to BM degradation and subsequent release of infected endothelial cells into the circulation and access into the CNS [@bib0355]. Viral hijacking of immune cells might also modulate vascular permeability. Bunyaviridae (Andes virus, ANDV), Dengue virus, HIV and West Nile virus (WNV) enhance dendritic cell (DC) maturation, MMP9 expression and plasma vascular leakage [@bib0360]. MMP9 is also upregulated in both the periphery and brain on WNV infection and is partly localized to brain blood vessels. WNV may enter the brain directly through the BBB or may be carried within infected leukocytes (described in the next section). WNV also upregulates MMP1 and MMP3 [@bib0365]. Coronaviruses can also induce MMPs in susceptible cells and have been associated with multiple sclerosis-like disease in rodents. However, the role of MMPs in coronavirus CNS infection is unknown [@bib0370]. Finally, it has been postulated that bovine herpesvirus 5 (BHV-5) entry the CNS is facilitated by leukocytes and MMP9. However, induction of MMP9 expression by BHV-5 has not been directly demonstrated so far [@bib0375].

Reports describing the involvement of serine protease activity in viral-induced BM distortion are scarce. As described above, EBV also induces uPA [@bib0325]. An unidentified trypsin-like serine protease is involved in BM crossing by the porcine pseudorabies virus (PRV) in porcine nasal respiratory explants [@bib0380].

In summary, several bacteria, fungi and viruses enhance invasion through the BM barrier by (mis)using proteolytic systems by encoding and/or modulating host-derived proteases.

Hitchhiking across the BM {#sec0045}
=========================

During physiological processes, such as development and immune surveillance, and during the pathology of many diseases, such as metastatic cancer, cells frequently traverse the BM barrier. Transmigration across the BM is a three-stage process ([Figure 1](#fig0005){ref-type="fig"}). First, invadopodia-like protrusions perforate the BM. Then these protrusions elongate in the degraded zone and infiltrate the underlying compartment. It is believed that the rod-like shape of invadopodia allows for focal delivery of proteases to restrictive areas of the BM [@bib0385]. Although the primary function of immune cells is to sample pathogens to initiate an immune response, over time, several pathogens have developed mechanisms to use these cells as Trojan horses to cross the BM barrier and disseminate throughout the host. Mechanisms of intracellular survival involving inhibition of immune cell activation via alteration of their phenotype and function contribute to cell migration according to direct and indirect evidence [@bib0390].

Several bacteria survive in polymorphonuclear neutrophil granulocytes (PMN) or neutrophils: *Anaplasma phagocytophilum*, *Bordetella pertussis*, *Brucella abortus*, *Chlamydia psittaci*, *Chlamydia trachomatis*, *Escherichia coli*, *Francisella tularensis*, *Mycobacterium leprae*, *Neisseria gonorrhoeae*, *Salmonella enterica* serovar Typhi, *Salmonella enterica* serovar Typhimurium, *S. aureus*, *S. pyogenes* and *Yersinia enterolytica*. This may provide a mechanism by which bacteria infect distant sites, although this needs further experimental confirmation. *Burkholderia pseudomallei*, *Chlamydia pneumoniae*, *Haemophilus somnus* and *Legionella pneumophila* not only survive but also multiply in PMN. Afterwards, pathogens may enter through the uptake of infected apoptotic PMN, survive and multiply in macrophages, which subsequently may transport bacteria throughout the body [@bib0395], [@bib0400].

The Trojan horse hypothesis is also valid for DCs. *Coxiella burnetii* survives in DCs during infection [@bib0405]. DCs also transport intracellular *Listeria monocytogenes*, *M. tuberculosis* and *S.* Typhimurium from mucosal areas towards the draining lymph nodes [@bib0410].

Mononuclear phagocytes (monocytes and macrophages) can also be misused by intracellular bacteria to disseminate throughout the host. This has been reported or suggested for uropathogenic *E. coli* [@bib0415], *L. pneumophila*, *Salmonella enterica* [@bib0420], *S.* Typhimurium [@bib0390] and *Yersinia pestis* [@bib0425]. Furthermore, *H. influenzae* has been found within mononuclear cells both above and below the BM [@bib0430]. Although *Bacillus anthracis* is not an intracellular pathogen, it can use alveolar macrophages to cross airway mucosal barriers [@bib0435]. Mononuclear phagocyte-facilitated entry into CNS across the BBB has been described for *Brucella* spp., *Ehrlichia chaffeensis*, *L. monocytogenes*, *M. tuberculosis* and *Streptococcus suis* type II in swine [@bib0390]. *L. monocytogenes* invades both directly and when carried within infected leukocytes [@bib0410].

Several pathogens, such as *Mycobacterium avium* [@bib0440] and *Shigella flexneri* [@bib0445], predominantly exploit M cells to cross the epithelial barrier into the subepithelial lamina propria and subsequently invade macrophages. As described earlier, *H. pylori* is associated with metastatic processes and the spread of malignant cells throughout the body [@bib0250].

Some fungi also exploit immune cells to cross host barriers. *Histoplasma capsulatun* causes systemic mycosis, mainly in immunosuppressed patients, and can survive and multiply in PMN [@bib0400]. It has been demonstrated that the facultative intracellular pathogen *C. neoformans* crosses the BBB via mononuclear phagocytes (monocytes and macrophages), together with other mechanisms involving free yeasts [@bib0450].

Several viruses hijack immune cells to transverse the BM ([Figure 2](#fig0010){ref-type="fig"}). DCs and Langerhans cells (LCs), an epidermal DC subtype, are located at mucosal or epidermal sites of entry for many viruses, such as herpesviruses, immunodeficiency viruses and HPV, and are thus of key importance in infections with these viruses. Initial infection of epidermal cells with herpes simplex virus type 1 (HSV-1) results in infection of resident LCs. After infection, a decrease in epidermal LC density and a corresponding increase in the number of langerin-positive cells in the underlying dermis has been noted, arguing for HSV-induced LC migration from the epidermal layer [@bib0455]. During primary infection with varicella zoster virus (VZV), another herpesvirus, DCs of the respiratory mucosa can transport VZV to human tonsillar CD4^+^ T lymphocytes, followed by T lymphocyte-mediated dissemination in the host [@bib0460]. HIV might use LCs for *trans*-epithelial transport of HIV to susceptible CD4^+^ T cells [@bib0465]. Measles virus (MV) is another virus that uses DCs to gain access to its main target cells in lymphoid tissues [@bib0470]. As described earlier, ANDV, Dengue virus, HIV and WNV hijack DCs [@bib0360].

HIV may use not only use LCs but also mononuclear phagocytes (monocytes/macrophages) for BM passage, which could contribute to their ability to invade the brain. Early in the course of infection, HIV-1 can enter the CNS. HIV encephalitis is characterized by HIV-laden monocytes and macrophage infiltration into CNS parenchyma. Local inflammation and HIV products such as gp120, Nef and Tat, which upregulate MMP2 and/or MMP9, lead to breaches in the BBB late in HIV CNS disease. This enables free virions to enter the brain [@bib0475], [@bib0480]. In addition, CMV-infected monocytes can enter the CNS in a Trojan horse model [@bib0390]. For WNV, LCs support initial viral replication, followed by replication in lymphoid tissues and dissemination to organs and the CNS [@bib0485]; WNV may enter the brain through the BBB either directly or carried within infected monocytes or macrophages (as described above) [@bib0365].

Recently, it has been shown that equine herpesvirus 1 (EHV-1) might use monocytes, macrophages and lymphocytes as Trojan horses to transport the virus through the BM in nasal mucosae. EHV-1-infected monocytes, macrophages and lymphocytes were found in connective tissue below the BM in close proximity to epithelial plaques, suggestive of leukocyte-mediated viral passage through the BM [@bib0490]. The closely related EHV-4 did not efficiently infect these local immune cells, which might be the reason why EHV-4-induced viremia is rare [@bib0490]. It has been postulated that BHV-5 might use a similar invasive mechanism as EHV-1 and that BHV-5 entry into the CNS is facilitated by leukocytes and MMP9 [@bib0375]. Lymphocyte-mediated viral entry into the brain has also been demonstrated for HTLV-1 [@bib0350]. The association with MMP activity was described earlier.

Some oncogenic viruses such as EBV, hepatitis B virus, HPV, HTLV-1 and KSHV drive tumor invasiveness and metastasis by modulating proteases ([Figure 2](#fig0010){ref-type="fig"}). However, the role of the spread of viral-infected malignant cells in the pathogenesis of these viruses is unclear at present.

In conclusion, different bacteria, fungi and viruses exploit host cells, particularly immune cells, to cross the BM barrier and disseminate throughout the host.

Concluding remarks and future perspectives {#sec0050}
==========================================

The BM represents a formidable barrier of the body against the outside world. However, it is clear that a wide array of pathogens have developed mechanisms to cross the BM and invade the host. There are several important outstanding questions about this still largely unexplored topic ([Box 1](#tb0005){ref-type="boxed-text"} ). One aspect of BM passage that we have not discussed here is the role of local immunity in breaking down ECM during a microbial infection. Indeed, immune cells produce a large amount of proteases on stimulation at sites of inflammation and this might rupture important barriers such as the BM, allowing pathogens access to deeper tissues. However, inflammation increases the risk that pathogens will be neutralized by the immune system.Box 1Outstanding questions•For what reason did certain pathogens, which might even belong to the same family, evolve different mechanisms of invasion? Did they co-evolve with their host?•Does tissue type play a role in the particular mechanism utilized for pathogen invasion? Alternatively, is tissue tropism driven by the invasion skills of a pathogen? How different are the BM composition and barrier function in different tissues of different species?•To what extent does inflammation really play a role in aiding pathogen invasion through the BM? Does immune evasion provide better and more rapid BM crossing?•What intrinsic capacities do viruses possess for host invasion?•Are the proteases involved in viral invasion produced by the virus or cellular proteases that are upregulated by the virus?

The BM represents one of the first barriers encountered by the pathogen, so dissection of pathogen interactions with and mechanisms to cross the BM may provide interesting leads towards the development of novel antimicrobial drugs. However, it is important to keep in mind that current detailed *in vitro* knowledge on this topic does not always translate to the *in vivo* situation as axiomatic truth. Improved *in vitro* models that better reflect the *in vivo* environment will provide excellent tools for the identification and characterization of putative adhesion and invasion mechanisms before progressing to the use of animal models.

An obvious target for preventing pathogen infiltration is the adhesion step to the BM. Moreover, it is important to know that different microbial invasive strategies might have synergistic effects on one another. Indeed, interactions between adhesion and proteolytic activity-mediating mechanisms to improve and enhance pathogen invasion have been described [@bib0495]. In some bacteria, production of proteases might even depend on quorum sensing [@bib0500]. Taking this possibility into account, hampering of bacterial adhesion might also influence proteolytic activity. Mechanisms underpinning binding to and breakdown of the BM are generally better understood for bacteria and fungi than for viruses. Hence, it will be interesting to identify possible viral factors that are required for efficient penetration through the BM and ECM. If protease activity plays a role, as described recently for a herpesvirus [@bib0380], then the use of protease inhibitors might be a useful strategy. However, to further develop the potential of proteases as antimicrobial targets, there is a need for identification of all signals, factors and domains involved during microbial invasion. Compounds that interfere with pathogen hijacking of migratory cells or limit interactions of metastatic cells with ECM elements could, if locally applied, provide an interesting way to prevent or delay further microbial invasion.

In conclusion, several bacteria, fungi and viruses have evolved different finely tuned techniques to adhere to, break down and/or hitchhike across the BM. Fundamental insights into these invasion mechanisms of pathogens could be a promising road towards new therapeutic approaches against these different types of pathogens.
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